Crinetics Pharmaceuticals, Inc. Other Nonoperating Income (Expense)
Crinetics Pharmaceuticals, Inc. (CRNX) reported Other Nonoperating Income (Expense) of -$423.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$423.00K, a 2215.00% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$131.00K.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$125.00K.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$49.00K.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for fiscal 2025 was -$357.00K.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for fiscal 2024 was -$519.00K.
- Crinetics Pharmaceuticals, Inc. other nonoperating income (expense) for fiscal 2023 was -$159.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$423.00K 10-Q · filed 2026-08-03 | -$554.00K 10-Q · filed 2026-08-03 | -$679.00K derived: sum of 3 quarters · filed 2026-08-03 | -$728.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$131.00K 10-Q · filed 2026-05-07 | -$256.00K derived: sum of 2 quarters · filed 2026-05-07 | -$305.00K derived: sum of 3 quarters · filed 2026-05-07 | -$285.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$174.00K derived: sum of 2 quarters · filed 2026-02-26 | -$154.00K derived: sum of 3 quarters · filed 2026-08-03 | -$357.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$49.00K 10-Q · filed 2025-11-06 | -$29.00K derived: sum of 2 quarters · filed 2026-08-03 | -$232.00K 10-Q · filed 2025-11-06 | -$450.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $20.00K 10-Q · filed 2026-08-03 | -$183.00K 10-Q · filed 2026-08-03 | -$401.00K derived: sum of 3 quarters · filed 2026-08-03 | -$438.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$203.00K 10-Q · filed 2026-05-07 | -$421.00K derived: sum of 2 quarters · filed 2026-05-07 | -$458.00K derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$255.00K derived: sum of 2 quarters · filed 2026-02-26 | -$519.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$37.00K 10-Q · filed 2025-11-06 | -$301.00K 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | -$159.00K 10-K · filed 2026-02-26 |